Shamloo (standford university) - mcsp-exploratory chemistry (EC)
Ended Awarded Last action
- Contract number
- 75N95022F00003
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,360,769
Award facts
- Contract value 100% obligated
- $3,360,769.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,441,922 | |
| Exercise an Option | $1,261,955 | |
| Original award | $656,892 |
About this award
This is a federal contract award to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The contract, valued at $3,360,769.23, is for the Medicinal Chemistry Support Program for Therapeutic Development (MCSP-EC), which involves exploratory chemistry services. The contract has a completion date of November 13, 2025 and was awarded on May 6, 2022. Curia Global is a leading contract development and manufacturing organization (CDMO) that has provided extensive pharmaceutical research and development support services to various NIH institutes through prime and subcontract awards. This award does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95022F00003?
75N95022F00003 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 6, 2022.
How much is contract 75N95022F00003 worth?
The government has obligated $3,360,769 on 75N95022F00003.
Which agency awarded contract 75N95022F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00003, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95022F00003 an order under another contract?
Yes. 75N95022F00003 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95022F00003 competed?
The extent of competition for 75N95022F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award